Cardiometabolic Comorbidities in Cancer Survivors | JACC: CardioOncology Author Discussion
JACC: CardioOncology Editor-in-Chief Dr. Bonnie Ky has a conversation with Drs. Leah Zullig, Kevin Oeffinger, and Susan Dent who serve as first, corresponding, and senior authors on a state-of-the-art review paper published in the June 2022 Issue of JACC: CardioOncology titled, “Cardiometabolic Comorbidities in Cancer Survivors.”
Related Manuscript: 10.1016/j.jaccao.2022.03.005
Cardiovascular Disease in Myeloproliferative Neoplasms | JACC: CardioOncology Author Discussion
JACC: CardioOncology Editor-in-Chief Dr. Bonnie Ky and first author Dr. Orly Leiva discuss the state-of-the-art review on the cardiovascular disease in myeloproliferative neoplasms
Role of Cardioprotection in Cancer Therapy Cardiotoxicity | JACC: CardioOncology Author Discussion
Editor-in-Chief Dr. Bonnie Ky talks with Dr. Torbjørn Omland, senior author of JACC: CardioOncology’s state-of-the-art review article titled, The Role of Cardioprotection in Cancer Therapy Cardiotoxicity, on synthesizing the most current evidence in cardioprotection.
Cardiac CV Toxicity of BRAF and MEK Inhibitors | JACC: CardioOncology Author Discussion
Watch EiC Dr. Bonnie Ky And Author Dr. Ninian Lang Discuss the State-of-the-Art Review on the Incidence and Mechanisms of BRAF/MEK-Associated Cardiovascular Toxicity.
-
-
JACC: CardioOncology - Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors: A Cross-Sectional Study
Coleen Power, RN MNJune 21, 2022
Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
Mini-Focus Issue: Physical Activity and Lifestyle Interventions in Cancer
JACC: CardioOncology Published How To Manuscripts
